KahnSRComerotaAJCushmanM, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2014;130(18):1636–1661.
2.
GuanellaRDucruetTJohriM, et al. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. J Thromb Haemost. 2011;9(12):2397–2405.
3.
KahnSR.The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Program. 2016;2016(1):413–418.
4.
VedanthamSGoldhaberSZJulianJA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377(23):2240–2252.
5.
ComerotaAJKearonCGuCS, et al. Endovascular thrombus removal for acute iliofemoral deep vein thrombosis. Circulation. 2019;139(9):1162–1173.
6.
DexterDJKadoHSchorJ, et al. Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-Comer CLOUT Registry. J Vasc Surg Venous Lymphat Disord. 2022;10(4):832–840.e2.
7.
NottenPde SmetAAEATickLW, et al. CAVA (ultrasound-accelerated catheter-directed thrombolysis on preventing post-thrombotic syndrome) trial: long-term follow-up results. J Am Heart Assoc. 2021;10(11):e018973.
8.
CaseyETMuradMHZumaeta-GarciaM, et al. Treatment of acute iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55(5):1463–1473.
9.
PounceyALGwozdzAMJohnsonOW, et al. AngioJet pharmacomechanical thrombectomy and catheter directed thrombolysis vs. catheter directed thrombolysis alone for the treatment of iliofemoral deep vein thrombosis: a single centre retrospective cohort study. Eur J Vasc Endovasc Surg. 2020;60(4):578–585.
10.
VedanthamSSalterALanciaS, et al. Clinical outcomes of a pharmacomechanical catheter-directed venous thrombolysis strategy that included rheolytic thrombectomy in a multicenter randomized trial. J Vasc Interv Radiol. 2021;32(9):1296–1309.e7.
11.
PrandoniPLensingAWACogoA, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1–7.
12.
PounceyALKahnTMorrisRI, et al. Risk factors and classification of reintervention following deep venous stenting for acute iliofemoral deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2022;10(5):1051–1058.e3.
CooleyBCChenC-YHessR, et al. Incomplete resolution of deep vein thrombosis under reduced flow conditions. Thromb Res. 2013;131(1):55–58.
15.
ClinicalTrials.gov. Bolt: study of the Indigo® aspiration system when used in patients with deep vein thrombosis—full text view. https://clinicaltrials.gov/ct2/show/NCT05003843. Accessed September 23, 2022.
